- Solutions Overview
- Clinical Development
- Outsourcing Services
- Parexel® Biotech
- Medical Affairs
- Real-World Evidence and Late Phase
- Our Company
- Management Team
- Diversity, Equity and Inclusion
- Career Opportunities
- Trust & Privacy
Emerging biotech companies like yours are dedicated to bringing groundbreaking medical innovations to patients who need them, and that means embarking on the development journey. It’s a journey that our biotech solutions were built for. We’ll walk with you step-by-step, through every decision, touchpoint, and milestone, to ultimately bring patients closer to better outcomes, together.
No matter the project, we put patients at the beginning, middle, and end of everything we do; leveraging their insights and letting them help guide us. It’s that patient-centricity, combined with our biotech services, global capabilities, and industry-leading expertise that add up to a more effortless journey to the most important endpoint.
Your goal is to improve patients’ lives. Our goal is to make that easier for you with a delivery model that is fully integrated and adaptable from the very beginning.
Every Parexel Biotech team is built to help you deliver innovations to the patients who need them most. We start with a single point of contact to coordinate every piece of your project, add a highly qualified, dedicated project team, and finally, we integrate service lines for a holistic and strategic approach.
We put patients at the heart of everything we do, and we’re not just saying that. It’s key to our culture and we live it every day. It’s about fully understanding our patients and their lives–from their psychological well-being, to their relationships and socioeconomic circumstances. This commitment drives everything from protocol design and endpoints, all way to the decisions made by our leadership team.
From pre-IND to Post-Approval, we integrate the essential service lines you need to address each challenge and keep you on the path to success, every step of the way.
No matter what you’re exploring, we can help you navigate competitive, regulatory, and reimbursement landscapes while innovating and streamlining your development plan with the help of real-world data.
Learn more about our presence in your local area and around the world on our Global Locations page.
Parexel Biotech’s leadership team knows on a personal level what it means to pursue ambitious goals, fight alongside patients, and constantly adjust and adapt to changing conditions. They understand your challenges because they’ve lived them in their own lives..
>> My name is Ubavka DeNoble. I'm Senior Vice President and I'm a senior medical advisor for Asia and for Europe. My best friend was diagnosed with epilepsy. Of course, -- you know, it's her best friend, I went through it with her and I know how difficult it is. When I joined the industry, the first drug that I worked on was an anti-epileptic drug and it was an on treatment drug. And discovering new drugs is not something that happened --you know, in few days or few months. This is tedious work, you have absolutely innovative science, and you have people that have great ideas. Sometimes they fail, if they fail, they get up and they continue. There is no other way.
>> When I was a little girl, my dream was to become a biochemist, and -- -- change the world -- improve the world's health. I always dreamt big. I went to the University and I got pregnant with my first girl. I had to pivot and switch to pharmacy. I graduated from pharmacy when my second kid was two months old. I never gave up. I continued studying because my dream was always to become a biochemist. And I graduated from biochemistry when my third kid was one year old. There were challenges throughout the whole journey. I had my family and I had managers supporting me. Well, I'm here to support these biotech companies achieve their goals, and they also dream big. I'm living my dream with Parexel Biotech.
>> There's probably no way I could have scripted it 20 years ago that I would end up here. But -- you know, from an early sort of academic focus on science and then in business. Early jobs as site coordinators, and enrolling patients in clinical trials, and then moving into the CRL space on the service side. And then going through the experience of losing my father to a still and uncured disease in dementia and Lewy body dementia. I just feel like it's so incredible that I'm here working with pharmaceuticals, and especially biotech companies every day to innovate and find new therapies. What's been amazing over the last few years is how the model has evolved. Not only is it fit for purpose and tailored for our customers, but we've really been able to offer all of our services in an integrated way across the development continuum. Starting with planning and consulting in regulatory work, delivering clinical trials, and now being able to help them register and commercialize those assets. It's been an amazing journey.
>> The real point here is, is it's not about the medicine on the device, it's about what we can do for the outcome of the patient. I had a mother who had multiple medical issues related to an automobile accident that she had when she was very young. And so I had a lot of exposure to hospitals, treatments, medications early on in my life. And I saw good medical care, and I saw not so good medical care. And each one of those instances was really important to me, and drive what I do today because I believe what we are doing is driving great medical care in the future.
>> I'm working for those patients that in the end, they see hope, -- you know, in the pharmaceutical industry providing a -- an alternative option for treatment. And what I do every day is not giving up on them.
>> We're so fortunate to be at the forefront of what's going to happen next. And every day through our customers we see those opportunities to treat patients and cure disease.
>> In Parexel we like to pride ourselves that everything that we do, we do with heart and you feel it.
[ Music ]
Whitepaper: COVID-19 Vaccination in Cancer Patients
Four Keys to a Smoother Clinical Development Journey
Top Ten Rules for Success in DCTs
Operationalizing Cell and Gene Therapy Trials
Decentralized Trials: Considerations for Building a New Patient-Centric Model
We are always available for a conversation.